- Featured Product
- KD/KO Validated
CoraLite® Plus 488-conjugated CAPZA1 Monoclonal antibody
CAPZA1 Monoclonal Antibody for IF/ICC
Host / Isotype
Mouse / IgG1
Reactivity
human
Applications
IF/ICC
Conjugate
CoraLite® Plus 488 Fluorescent Dye
CloneNo.
10H1F9
Cat no : CL488-66066
Synonyms
Validation Data Gallery
Tested Applications
Positive IF/ICC detected in | MCF-7 cells |
Recommended dilution
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
The immunogen of CL488-66066 is CAPZA1 Fusion Protein expressed in E. coli.
Tested Reactivity | human |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Immunogen | CAPZA1 fusion protein Ag18841 相同性解析による交差性が予測される生物種 |
Full Name | capping protein (actin filament) muscle Z-line, alpha 1 |
Calculated molecular weight | 286 aa, 33 kDa |
GenBank accession number | BC000144 |
Gene symbol | CAPZA1 |
Gene ID (NCBI) | 829 |
RRID | AB_2883248 |
Conjugate | CoraLite® Plus 488 Fluorescent Dye |
Excitation/Emission maxima wavelengths | 493 nm / 522 nm |
Form | Liquid |
Purification Method | Protein G purification |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
CAPZA1 (F-actin-capping protein subunit alpha-1) is a member of the F-actin capping protein alpha subunit family and regulates actin filament growth, stability and disassembly. Differential expression of CAPZA1 has been found in gastric cancer and melanoma, indicating its possible role in tumorigenesis. (21566537, 23545944)
Protocols
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 CAPZA1 antibody CL488-66066 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |